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Abstract 
An efficient protocol for the synthesis of differently substituted 1, 4-
dihydropyridines in deep eutectic solvents under solvent-free conditions is 
reported herewith. Excellent yields of the resultant products have been obtained. 
Recyclability studies have also been performed for deep eutectic solvents with 
very little loss in activity up to five recycles. 
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1. Introduction 
1,4-Dihydropyridines (1,4-DHPs) are an important class of bioactive molecules, well known 
for their role as calcium channel modulators and used extensively for the treatment of 
hypertension.1-3 The derivatives of 1,4-DHPs have shown a variety of biological activities 
such as vasodilator, bronchodilator, antitumor, hepatoprotective and geroprotective activity.4,5 
Commercial drugs such as Nifedipine which are a prototype of the 1,4-DHP structure has 
been used extensively in both antianginal and antihypertensive treatment.6 
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One-pot multi-component reactions are of increasing academic and ecological interest 
due to the possibility of achieving high synthetic efficiency and reaction design.7 The 
classical method for the synthesis of 1,4-DHPs involves the one-pot condensation of three or 
more components under relatively harsh conditions using ammonia as the nitrogen source.8 
Drastic reduction in reaction times and improved reactivity of the synthetic procedures have 
been brought about by the application of microwave.9 Although, impressive levels of activity 
could be achieved, large scale synthesis is a problem. Similarly, Lewis acid catalysts such as 
Yb(OTf)3 have been shown to catalyze the reactions at ambient temperature.10 
Recently, Zhao et.al. reported the synthesis of 1,4-DHP derivatives in ionic liquids.11 
Ionic liquids have attracted lot of attention during the past decade in the context of green 
chemistry due to their low vapour pressure, high thermal stability and their solvation 
properties which make them such unique solvents in synthesis.12 However, serious limitations 
have emerged for the industrial scale application of ionic liquids such as high cost,13 
environmental toxicity14 and the demand for high purity which could otherwise lead to 
change in the physical properties of the ionic liquids.15,16 The development of alternative 
solvents from components that are inexpensive, non-toxic towards the environment and are 
biodegradable is therefore highly desirable to overcome these drawbacks.  
One such alternative approach could be the use of deep eutectic mixtures (DES) 
which were first synthesized by Abbott et.al.17 and since then found wide scope in an array of 
biological applications due to their biodegradable properties. Most common of them are the 
biological transformations such as hydrolase catalyzed biotransformation18 and extraction of 
glycerol from biodiesel into a eutectic-based solvent.19 Although attractive, deep eutectic 
mixtures have seldom been used for organic transformations.20 We therefore thought it would 
be interesting to try the application of DES for one-pot synthesis of 1, 4-dihydropyridines and 
it worked very efficiently. A mixture of aldehyde 2a-n, dimedone 3, ethyl acetoacetate 4 and 
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ammonium acetate 5 in DES 1a on heating resulted in the formation of 1, 4-dihydropyridines 
6a-n. 
2. Experimental 
2.1 Materials 
All common reagents and solvents were used as obtained from commercial supplies without 
further purification.  
2.2 Apparatus 
All melting points were determined in open capillaries using Gallen Kamp melting point 
apparatus and are uncorrected. All PMR spectra were recorded in CDCl3 (chemical shift in 
delta) using Bruker AV 200 spectrophotometer (300 MHz). 
2.3 Representative procedure for the preparation of Deep Eutectic Solvent 1a. 
Choline chloride A (2.8 g, 20 mmol) and urea B (a) (2.4 g, 40 mmol) were placed in a round 
bottomed flask and heated to 60◦C, until liquid began to form. After 10 min, a homogenous 
colourless liquid was formed which was used directly for the reactions. 
2.4 Representative procedure for the synthesis of 1, 4-DHP Derivatives 6a-n. 
2a-n (1.0 mmol), 3 (0.140 g, 1.0 mmol), 4 (0.130 g, 1.0 mmol), 5 (0.115 g, 1.5 mmol) and 
DES (Deep Eutectic Solvent) 1a (2.0 mL) were successively charged into a schlenk tube 
equipped with a magnetic stirrer. Then the reaction was stirred at 60 °C for 20 minutes and a 
solid product gradually formed. After the completion of reaction as indicated by TLC, water 
was added, the reaction mass was stirred and the mixture was filtered. The crude product 
obtained was purified by recrystallization using absolute alcohol. Further water was removed 
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under vacuum at 80 0C leaving behind deep eutectic solvent which was used up to 5 recycles. 
A detailed account of the recycle studies is mentioned in results and discussion. 
2.5 Spectroscopic data of selected compounds 
Ethyl-1,4,5,6,7,8-hexahydro-2,7,7-trimethyl-5-oxo-4-phenylquinoline-3-carboxylate (6a). 
m.p: 203–2040C. IR (KBr in cm-1) 3233, 3210, 3080, 1696, 1602, 1059, 692, 1H NMR 
(CDCl3, 300 MHz): δ 0.94 (s, 3H), 1.07 (s, 3H), 1.21 (t, J = 7.1 Hz, 3H), 2.13–2.29 (m, 4H), 
2.35 (s, 3H), 4.06 (q, J = 7.1 Hz, 2H), 5.07 (s, 1H), 6.25 (s,1H), 7.08–7.13 (m, 1H), 7.18–7.23 
(m, 2H), 7.28–7.33 (m, 2H). ESI-MS (m/z) 340 (M+H)+. Analysis calculated for C21H25NO3: 
C, 74.31; H, 7.42; N, 4.13. Found: C, 74.27; H, 7.39; N, 4.08. 
Ethyl-1,4,5,6,7,8-hexahydro-2,7,7-trimethyl-5-oxo-4-p-tolylquinoline-3-carboxylate (6b). 
m.p: 260–2620C. IR (KBr in cm-1) 3287, 3031, 2958, 1644, 1596, 1480, 1334, 1213, 757, 1H 
NMR (CDCl3, 300 MHz): δ 0.94 (s, 3H), 1.08 (s, 3H), 1.21 (t, J = 7.1 Hz, 3H), 2.10–2.24 (m, 
4H), 2.26 (s, 3H), 2.37 (s, 3H), 4.06 (q, J = 7.1 Hz, 2H), 5.03 (s, 1H), 5.96 (s, 1H), 7.02 (d, J 
= 8.0 Hz, 2H), 7.19 (d, J = 8.0 Hz, 2H). ESI-MS (m/z) 354 (M+H)+. Analysis calculated for 
C22H27NO3: C, 74.76; H, 7.70; N, 3.96. Found: C, 74.74; H, 7.65; N, 3.91. 
Ethyl-1,4,5,6,7,8-hexahydro-4-(4-methoxyphenyl)-2,7,7-trimethyl-5-oxoquinoline-3-
carboxylate (6c). m.p: 256-2570C. IR (KBr in cm-1) 3281, 3199, 3080, 1708, 1607, 1224, 
837, 1H NMR (CDCl3 300 MHz,): δ 0.94 (s, 3H), 1.07 (s, 3H), 1.21 (t, J = 7.2 Hz, 3H), 2.09-
2.20 (m, 4H), 2.36 (s, 3H), 3.73 (s, 3H), 4.04 (q, J = 7.2 Hz, 2H), 4.99 (s, 1H), 6.06 (s, 1H), 
6.65 (d, J = 7.3 Hz, 2H), 7.24 (d, J = 7.3 Hz, 2H ). ESI-MS (m/z) 370 (M+H)+
.
 Analysis 
calculated for C22H27NO4: C, 71.54; H, 7.31; N, 3.79; Found: C, 71.59; H, 7.35; N, 3.84. 
Ethyl-1,4,5,6,7,8-hexahydro-4-(4-hydroxyphenyl)-2,7,7-trimethyl-5-oxoquinoline-3-
carboxylate (6d). m.p: 232–2340C. IR (KBr in cm-1) 3285, 1690, 1617, 1229, 1H NMR 
(CDCl3, 300 MHz): δ 0.94 (s, 3H), 1.08 (s, 3H), 1.19 (t, J = 7.2 Hz, 3H), 2.09–2.19 (m, 4H), 
2.34 (s, 3H), 4.06 (q, J = 7.6 Hz, 2H), 4.72 (s, 1H), 4.98 (s,1H), 5.61 (s, 1H), 6.65 (d, J = 8.9 
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Hz, 2H), 7.17 (d, J = 8.4 Hz, 2H). ESI-MS (m/z) 356 (M+H)+
.
 Analysis calculated for 
C21H25NO4: C, 70.98; H, 7.04; N, 3.94; Found: C, 70.96; H, 7.02; N, 3.93. 
Ethyl-1,4,5,6,7,8-hexahydro-2,7,7-trimethyl-4-(4-nitrophenyl)-5-oxoquinoline-3-
carboxylate (6e). m.p: 241-2430C. IR (KBr in cm-1) 3290, 3150, 1711, 1657, 1H-NMR 
(CDCl3 300 MHz,): δ 0.9 (s, 3H), 1.08 (s, 3H), 1.82 (t, J = 7.1 Hz, 3H), 2.16-2.36 (m, 4H), 
2.40 (s, 3H), 4.01 (q, J = 7.1 Hz, 2H), 5.15 (s, 1H), 6.31 (s, 1H), 7.51 (d, J = 8.2 Hz, 2H), 
8.09 (d, J = 8.3 Hz, 2H). ESI-MS (m/z) 385 (M+H)+
.
 Analysis calculated for C21H25N2O5 C, 
65.45; H, 6.49; N, 7.27. Found: C, 65.43; H, 6.49; N, 7.28.
 
Ethyl-4-(2-chlorophenyl)-1,4,5,6,7,8-hexahydro-2,7,7-trimethyl-5-oxoquinoline-3-
carboxylate (6f). m.p: 208-2100C. IR (KBr in cm-1) 3062, 2955, 1720, 1640, 1610, 1468, 
1385, 1228, 1020, 745, 1H NMR (CDCl3, 300 MHz): δ 0.95 (s, 3H), 1.07 (s, 3H), 1.17 (t, J = 
7.1 Hz, 3H), 2.15–2.23 (m, 4H), 2.30 (s, 3H), 4.04 (q, J = 7.1 Hz, 2H), 5.38 (s, 1H), 6.11 (s, 
1H), 6,98 (m, 1H), 7.15–7.19 (m, 1H), 7.24–7.26 (m, 1H), 7.41-7.44 (m, 1H). ESI-MS (m/z) 
374 (M+H)+
.
 Analysis calculated for C21H24ClNO3: C, 67.43; H, 6.47; N, 3.75. Found: C, 
67.44; H, 6.48; N, 3.72. 
Ethyl-4-(4-(dimethylamino)phenyl)-1,4,5,6,7,8-hexahydro-2,7,7-trimethyl-5-
oxoquinoline-3-carboxylate (6i). m.p: 229-2310C. IR (KBr in cm-1) 3287, 3018, 2964, 1602, 
1510, 1377, 1207, 751, 1H NMR (CDCl3, 300 MHz): δ 0.96 (s, 3H), 1.07 (s, 3H), 1.22 (t, J = 
7.1 Hz, 3H), 2.18–2.27 (m, 4H), 2.35 (s, 3H), 2.86 (s, 6H), 4.05 (q, J = 7.1 Hz, 2H), 4.95 (s, 
1H), 5.88 (s, 1H), 6.60 (d, J = 8.6 Hz, 2H), 7.16 (d, J = 8.6 Hz, 2H). ESI-MS (m/z) 383 
(M+H)+
.
 Analysis calculated for C23H30N2O3: C, 72.22; H, 7.91; N, 7.32. Found: C, 72.18; H, 
7.85; N, 7.25. 
 Ethyl-4-(4-chlorophenyl)-1,4,5,6,7,8-hexahydro-2,7,7-trimethyl-5-oxoquinoline-3-
carboxylate (6j). m.p: 245–2460C. IR (KBr in cm-1) 3275, 3200, 3075, 2965, 1705, 1650, 
1605, 1H NMR (CDCl3, 300 MHz): δ 0.93 (s, 3H), 1.08 (s, 3H), 1.19 (t, J = 7.1 Hz, 3H), 
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2.15–2.23 (m, 4H), 2.38 (s, 3H), 4.04 (q, J = 7.1 Hz, 2H), 5.02 (s, 1H), 5.90 (s, 1H), 7.15–
7.19 (m, 2H), 7.24–7.26 (m, 2H). ESI-MS (m/z) 374 (M+H)+
.
 Analysis calculated for 
C21H24ClNO3: C, 67.46; H, 6.47; N, 3.75. Found: C, 67.43; H, 6.49; N, 3.73. 
Ethyl-1,4,5,6,7,8-hexahydro-2,7,7-trimethyl-4-(3-nitrophenyl)-5-oxoquinoline-3-
carboxylate (6k). m.p: 177–1780C. IR (KBr in cm-1) 3303, 2954, 1683, 1610, 1167, 759, 1H 
NMR (CDCl3, 300 MHz): δ 0.89 (s, 3H), 1.05 (s, 3H), 1.22 (t, J = 7.1 Hz, 3H), 2.12–2.23 (m, 
4H), 2.38 (s, 3H) 4.03 (q, J = 7.1 Hz, 2H), 5.16 (s, 1H), 6.85 (s, 1H), 7.36 (t, J = 7.9 Hz, 1H), 
7.71 (d, J = 7.9 Hz, 1H), 7.97 (m, 1H), 7.99 (m, 1H). ESI-MS (m/z) 385 (M+H)+
.
 Analysis 
calculated for C21H25N2O5: C, 65.45; H, 6.49; N, 7.27. Found: C, 65.44; H, 6.48; N, 7.26. 
Ethyl-1,4,5,6,7,8-hexahydro-2,4,7,7-tetramethyl-5-oxoquinoline-3-carboxylate (6l). m.p: 
201–2030C. IR (KBr in cm-1) 3287, 2947, 1685, 1147, 751, 1H NMR (CDCl3, 300 MHz): δ 
0.98 (d, 3H), 1.09 (s, 6H), 1.26-1.31 (t, 3H), 2.11–2.32 (m, 7H), 3.91-3.93 (q, 1H), 4.17-
4.18(m, 2H), 5.6 (s, 1H). ESI-MS (m/z) 278 (M+H)+. Analysis calculated for C16H23NO3: C, 
69.31; H, 8.30; N, 5.05. Found: C, 69.29; H, 8.29; N, 5.06. 
Ethyl-4-ethyl-1,4,5,6,7,8-hexahydro-2,7,7-trimethyl-5-oxoquinoline-3-carboxylate (6m). 
m.p: 143-1450C. IR (KBr in cm-1) 3288, 2954, 1686, 1167, 759, 1H NMR (CDCl3, 300 MHz) 
: δ 0.74 (t, J = 7.2 Hz 3H), 1.10 (s, 6H), 1.26-1.30 (m, 5H), 2.12–2.34 (m, 7H),  4.02 (t, J = 
6.2 Hz, 1H), 4.16 (m, 2H), 5.58 (s, 1H). ESI-MS (m/z) 292 (M+H)+. Analysis calculated for 
C17H25NO3: C, 70.10; H, 8.59; N, 4.89. Found: C, 70.12; H, 8.57; N, 4.87. 
Ethyl-4-butyl-1,4,5,6,7,8-hexahydro-2,7,7-trimethyl-5-oxoquinoline-3-carboxylate (6n). 
m.p: 165-1670C. IR (KBr in cm-1) 3290, 3090, 1690, 1197, 751, 1H NMR (CDCl3, 300 MHz): 
δ 0.82 (t, J = 7.1 Hz 3H), 1.09 (s, 6H), 1.15-1.41 (m, 9H), 2.19–2.30 (m, 7H), 4.01 (t, J = 6.1 
Hz, 1H), 4.17 (m, 2H), 5.77 (s, 1H).  ESI-MS (m/z) 320 (M+H)+. Analysis calculated for 
C19H29NO3: C, 71.47; H, 9.09; N, 4.38. Found: C, 71.45; H, 9.07; N, 4.40.  
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3. Results and Discussions 
We first set out to prepare series of deep eutectic solvents as mixtures of A with 
amides Ba-c (ratio 1:2) and A with carboxylic acids Bd-f (ratio 1:1) (Scheme-1,Table 1).17 
We first tested DES 1a-f as solvents for the synthesis of 1, 4-DHPs in a one-pot multi-
component reaction between 2a-n, 3, 4 and 5. A direct comparison of DES as solvent, with 
water and under solventless conditions was also carried out. Initial experiments suggested 
that the reactions initiated in DES 1a-f gave better yields of the desired products at an 
optimum temperature of 60oC as compared to water as solvent and under solventless 
conditions. Interestingly, 1a proved superior even to others, enabling the synthesis of the 1, 4-
DHPs in excellent yield (95.0%, Entry 1, Table 2). Polar and non-polar organic solvents 
(Entry 11-13, Table 2) when employed as solvents under similar reaction conditions showed 
poor conversion to the 1, 4-DHPs. These results highlight the potential of deep eutectic 
solvents 1a-f for promoting synthetically important transformations in comparison to the 
conventional solvent systems. Easy work-up procedures could be employed to obtain the 
product for deep eutectic solvents as they could be easily washed away with water suggesting 
their biocompatible nature. 
Encouraged by the above results we probed the applicability of DES 1a as the 
optimum solvent for the synthesis of 1, 4-DHPs in Scheme-2. A variety of substituted 
aldehydes underwent smooth conversion to the desired products. Presence of electron-
withdrawing or electron-donating substituents had no influence on the outcome of the 
reaction with both giving excellent yields. Unsubstituted benzaldehyde (Entry 1, Table 3) 
gave the best results followed by electron-withdrawing –NO2 (Entry 5, Table 3) and –Cl 
(Entry 6, Table 3) groups. The electron-donating –OMe (Entry 3, Table 3) or –Me (Entry 2, 
Table 3) weren’t far behind. Highly substituted aldehydes such as vanillin (Entry 7, Table 3) 
and 5-bromo vanillin (Entry 8, Table 3) also gave well to excellent yields of the 1, 4-DHP 
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products. It was further observed that even aliphatic aldehydes gave products in good yields 
(Entry 12-13, Table 3). The generality of the protocol is thus exhibited allowing efficient 
synthesis of differently substituted 1, 4-DHPs. 
3.1 Recycle study of Deep eutectic Solvent 
The ability to recover and recycle the solvent used in reaction is an important aspect to green 
chemistry. Therefore in present study we also evaluated the recyclability and reusability of 
this deep eutectic solvent (Table 4). 
4. Conclusion 
In summary a very simple approach towards one-pot multi-component synthesis of 1, 4-
Dihydropyridine Derivatives was developed using Biocompatible Deep Eutectic solvents. 
The deep eutectic solvents gave excellent recyclability without loss of activity up to 5 cycles 
hence providing a greener alternative. A milder and highly efficient protocol was developed 
which can easily replace existing methods. 
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